PUBLIC COMPANY
saveBlueprint Medicines Corp
updated 21d ago
community read0 votes
pipeline
4
marketed
2
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(4)
pipeline depth4 products
1Phase 21Phase 32Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- —Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
- phase2A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- phase3(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
- —An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
- phase2Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
- phase2(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis
- —A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
- phase1A Study of Elenestinib in Healthy Adult Female Participants
🐶 Hiring Signal
News
- 7 biopharma M&A deals where layoffs followedWorkforce cuts this year at seven companies involved in recent mergers and acquisitions will cost over 1,300 employees their jobs. Affected businesses include Arcellx and Tourmaline Bio, acquired b…biospace · 1d ago
- STAT+: Doritos as farm-to-table snacks? Big Food, under duress, gets creativeDoritos in the classic nacho cheese flavor have 27 ingredients, including not just familiar ones but also a number of additives and preservatives.stat · 3d ago
- STAT+: Sanofi to lay off 229 workers in Mass., a year after $9.1B Blueprint Medicines acquisitionSanofi, one of the Massachusetts' largest pharmaceutical employers, will lay off more than 200 workers there a year after acquiring Blueprint Medicines.stat · 3d ago
comments(0)
5-min edit window · permanent after that